On the role of allergen-specific IgG subclasses for blocking human basophil activation.

Zinkhan, Simon; Thoms, Franziska; Augusto, Gilles; Vogel, Monique; Bachmann, Martin F (2022). On the role of allergen-specific IgG subclasses for blocking human basophil activation. Frontiers in immunology, 13(892631), p. 892631. Frontiers Research Foundation 10.3389/fimmu.2022.892631

[img]
Preview
Text
fimmu-13-892631.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (4MB) | Preview

Successful treatment of IgE mediated allergies by allergen-specific immunotherapy (AIT) usually correlates with the induction of allergen-specific IgG4. However, it is not clear whether IgG4 prevents the allergic reaction more efficiently than other IgG subclasses. Here we aimed to compare allergen-specific monoclonal IgG1 and IgG4 antibodies in their capacity to inhibit type I allergic reactions by engaging FcγRIIb. We found that IgG1, which is the dominant subclass induced by viruses, binds with a similar affinity to the FcγRIIb as IgG4 and is comparable at blocking human basophil activation from allergic patients; both by neutralizing the allergen as well as engaging the inhibitory receptor FcγRIIb. Hence, the IgG subclass plays a limited role for the protective efficacy of AIT even if IgG4 is considered the best correlate of protection, most likely simply because it is the dominant subclass induced by classical AITs.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Rheumatology and Immunology
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR)
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Rheumatologie
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Rheumatologie

UniBE Contributor:

Zinkhan, Simon, Sousa Augusto, Gilles Anderson, Vogel, Monique, Bachmann, Martin (B)

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1664-3224

Publisher:

Frontiers Research Foundation

Language:

English

Submitter:

Pubmed Import

Date Deposited:

25 Oct 2022 15:42

Last Modified:

29 Mar 2023 23:38

Publisher DOI:

10.3389/fimmu.2022.892631

PubMed ID:

36275723

Uncontrolled Keywords:

FcγRIIb IgG1 IgG4 allergen allergen-specific immunotherapy basophil activation basophils

BORIS DOI:

10.48350/174063

URI:

https://boris.unibe.ch/id/eprint/174063

Actions (login required)

Edit item Edit item
Provide Feedback